miScript miRNA QC PCR Array

Offered by QIAGEN, this miRNA PCR Array is part of the Assay Technologies portfolio. The product is being discontinued, with manufacturing scheduled to cease on May 1, 2021, although remaining stocks will continue to be available for purchase. As a recommended successor, QIAGEN directs users to the miRCURY LNA miRNA QC PCR Panel, which is built on locked nucleic acid (LNA)-enhanced primer technology.

The successor platform supports both SYBR Green- and probe-based detection chemistries and combines a universal reverse transcription reaction with LNA-enhanced qPCR primers. This design enables highly specific quantification of miRNA targets, including low-abundance species, without requiring a preamplification step. SYBR Green detection allows melting curve analysis immediately after PCR to confirm reaction specificity, while probe-based formats deliver highly sensitive and robust target detection.

Within the Assay Technologies portfolio group, this product is classified under the Consumables budget line.